| (210) | Number of the EPO application | 17784089 |
| (220) | Filing date of the EPO application | 2017.09.22 |
| (80) | EPO patent specification publication (B) | EPB nr. 29/2023, 2023.07.19 |
| (110) | EPO patent number | 3515487 |
| (11) | Number of the document | MD 3515487 T2 |
| (21) | Number of the application | e 2019 0826 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | HABER Lauric, US;
SMITH Eric, US;
KELLY Marcus, US;
KIRSHNER Jessica R., US;
COETZEE Sandra, US;
CRAWFORD Alison, US;
NITTOLI Thomas, US;
LIU Yashu, US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | Bi specific anti-MUC16-CD3 antibodies and anti-MUC16 drug conjugates |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01); C07K 16/30 (2006.01.01); C07K 16/44 (2006.01.01); C07K 16/46 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.11.30 |
| (30) | Priority | 201662399249 P, 2016.09.23, US; 201762558711 P, 2017.09.14, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/US2017/053113, 2017.09.22 |
| (87) | International publication | WO 2018/067331, 2018.04.12 |